Stanford School of Medicine

Only 5% of American adults meet the daily recommended intake for fiber – and the consequences go well beyond digestion. Here’s what nutrition researchers want you to know.

At the ceremony in Maples Pavilion, dean Lloyd Minor urged graduates to take their hard-won resilience and inspire hope in others.

A federal grant launches the Center for Phage Pharmaceuticals, which will develop bacteriophage therapies to defeat antibiotic-resistant “superbugs” increasingly common in hospitals.

From empowering patients to rethinking how doctors and AI work together, Stanford’s weeklong symposium surfaced the ideas most likely to shape medicine’s next chapter.

A proposed cancer center in Redwood City would combine care and research to advance treatments for a growing patient population.

Highly addictive and marketed to teens, nicotine pouches are becoming increasingly popular. A Stanford Medicine researcher shares five things to know.

Stanford Medicine researchers found a way to enhance natural killer cells to better infiltrate and fight solid tumors in mice, with implications for more accessible cancer treatment.

In a small pilot study, a Stanford Medicine-developed tool showed promise by decreasing physician burnout while maintaining safety.

Stanford Medicine’s new proton therapy facility is ready for patients. On June 4 a child with a rare brain tumor became the first to receive treatment.

Research shows that obexelimab halves relapse risk in patients with IgG4-related disease, a chronic immune condition often misdiagnosed as cancer.